SS

Shyam Sunder Sharma

Director Director DIN 06496026
DIN 06496026 First appointment Feb 2013 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Feb 2013
Shareholding value β€’β€’β€’β€’ Premium profile

About Shyam Sunder Sharma

Data last updated:

Shyam Sunder Sharma has 13 years in corporate governance. Formerly with 1 company, such as Medglobe Therapeutics Limited. Engaged in General Business. Contributes to corporate operations.

DIN 06496026
Primary Designation Director
First Appointment 18 Feb 2013
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medglobe Therapeutics Limited U24239DL2006PLC368703
Director18 Feb 20132006₹21.04 Cr (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medglobe Therapeutics Limited
Premium access

Shareholding and investment profile for Shyam Sunder Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shyam Sunder Sharma

Shyam Sunder Sharma has 13 years in corporate governance. Formerly with 1 company, such as Medglobe Therapeutics Limited. Engaged in General Business. Contributes to corporate operations.

Shyam Sunder Sharma has expertise in General Business.

Shyam Sunder Sharma has 13 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available